by Garth Sundem | Jun 17, 2019 | Latest News, Research
Elena Shagisultanova, MD, PhD (left), and Virginia Borges, MD, MMSc The growth of some breast cancers is driven by hormones like estrogen and progesterone. Other breast cancers are driven by changes in the gene HER2. Still some cancers are driven by both – and breast...
by Garth Sundem | Jun 17, 2019 | Featured, Latest News, Patient Care
Jennifer Diamond, MD OnKure, Inc. and the University of Colorado Cancer Center announced enrollment of the first patient in a first-in-human phase 1 clinical trial testing investigational anti-cancer agent OKI-179, a novel and Class-selective HDAC inhibitor, in...
by Garth Sundem | Jun 5, 2019 | Honors, Latest News
Tyler Robin, MD, PhD When Tyler Robin, MD, PhD, graduates from the Radiation Oncology Residency Program at University of Colorado Anschutz Medical Campus at the end of June, he won’t have to move far – after graduation, Robin will make the leap from trainee to...
by Taylor Abarca | Jun 2, 2019 | Featured, Latest News, Patient Care
Johnna Vinson, after treatment Johnna Vinson knew something was very wrong, but she couldn’t seem to get an answer even after months of testing. In July of 2017 she found herself in the emergency room with the words “another 24 hours and you probably wouldn’t be here”...
by Garth Sundem | Jun 1, 2019 | Featured, Latest News
Thomas Flaig, MD University of Colorado Cancer Center led clinical trial data show that a predictive tool called COXEN may show which bladder cancer patients will respond to pre-surgical chemotherapy, a step towards allowing doctors to offer such chemotherapy to...
by Taylor Abarca | May 31, 2019 | Featured, Latest News, Research
Chicago, IL – 2018 ASCO Annual Meeting – Bradley Corr at the American Society of Clinical Oncology (ASCO) Annual Meeting here today, Friday June 8, 2018. Photo by © ASCO/Todd Buchanan 2018 Corr Bradley Patients with recurrent, heavily pretreated ovarian...
